Education & Information
Metastatic breast cancer (MBC) is breast cancer that has spread beyond the breast to other organs in the body. MBC is the most advanced stage of breast cancer—also known as Stage IV. It causes nearly all of the more than 41,000 breast cancer deaths each year in the United States.
In the U.S., it's estimated that at least 154,000 people have MBC. We want everyone to benefit from the scientific discoveries that are improving treatment for MBC and have the information and support needed to face the unique challenges and concerns of living with MBC. Komen works with partners in thousands of communities to unlock the scientific discoveries and deliver the support needed to help people with MBC.
Researchers do not fully understand what causes MBC and, as a result, don’t yet know how to prevent or treat it effectively. But they are working hard to find answers, and Komen is dedicated to helping them. Our research investment: More than $166 million in over 400 research grants and more than 40 clinical trials focused on metastatic breast cancer.
Clinical trials are key to making progress against metastatic breast cancer. Patients who join clinical trials receive high-quality patient care and at the same time, are contributing to the research process that could help themselves or others. Komen wants to help people with MBC find—and participate in—clinical trials, including many funded by Komen.
Special thanks to Odonate for sponsoring the Breast Cancer Clinical Trials Information Helpline.
More than 40,000 women and men in the U.S. will die from metastatic breast cancer this year alone. That’s one death every 13 minutes. Thanks to the support of people like you, we’re making things happen. We won’t stop until no one dies from breast cancer. Every step, every dollar, and every voice matters. Take an active role in the fight against MBC by getting involved today!